Treatment-focused DNA testing for newly diagnosed breast cancer patients: some implications for clinical practice
There is accumulating evidence that women with breast cancer due to a familial BRCA1 or BRCA2 mutation benefit from specific surgical and chemotherapeutic treatment strategies. However, the rapid identification of such patients during the acute phase of treatment raises a number of issues. This stud...
| Main Authors: | , , , |
|---|---|
| Format: | Journal Article |
| Published: |
Wiley-Blackwell Publishing, Inc.
2010
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.11937/38468 |